Biotech financing: darkest before the dawn After a difficult three years, biotech financing may slowly be returning to health.
Continue ReadingPharmaceuticals from marine sources: past, present and future An overview of why marine natural products are an attractive prospect for future drug discovery, including history of the field, successes in the clinic and challenges associated with gaining clinical approval.
Continue ReadingIndustrial Scale Microbiome Mining with Biosortia’s Ross Youngs
Continue ReadingThe Microbiome Mavericks: How These Startups Are Rewriting the Rules of Medicine and Health.
Continue ReadingIndustrial Scale Microbiome Mining is a New Drug Discovery Toolbox
Continue ReadingUnlocking The Secrets Of The Microbial World: The Pioneering Work Of Biosortia
Continue ReadingWhat’s in store for biotech in 2023? Perhaps 2022 will best be remembered in the life science industry for the return of many of the face-to-face events that fell by the wayside during the COVID-19 pandemic.
Continue ReadingBiosortia Microbiomics to Present at Biotech Showcase™ 2023 Biosortia’s proven technology obtains nature’s previously inaccessible drug-like small molecules for treatments and cures
Continue Reading